Pharma Journalist -

Mateon Therapeutics, Inc. dedicated to development OT-101, a TGF-Beta antisense drug candidate, provided an update on its rapid antiviral response program initially targeting the…
Read More...

SMi Reports: Conference highlights for AI in Drug Discovery conference taking place in London, this March. With less than 2 weeks to go for the highly anticipated AI in Drug…
Read More...

Samsung Biologics (207940.KS) and STCube announced a strategic development and manufacturing service agreement for STT-003 antibody, an anti-cancer drug candidate. Under the…
Read More...

Gilead Sciences, Inc. and Forty Seven, Inc. announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Forty Seven for $95.50 per share…
Read More...

Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select non-core products exclusively in Latin America to Hypera S.A.,…
Read More...

Genentech, a member of the Roche Group announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Esbriet (pirfenidone) for adults with…
Read More...

SMi Group have released an interview with Stephen Hunt, Professor at UCL, where he discussed his expertise and role in the industry, what he’s looking forward to at this year’s Pain…
Read More...

zPREDICTA is pleased to announce that it has entered into a strategic collaboration with LabCorp, a leading global life sciences company. The agreement will support the adoption of…
Read More...

Altasciences, a mid-size CRO specializing in a flexible, innovative approach to providing comprehensive early stage drug development from lead candidate selection to proof of concept,…
Read More...

Biogen Inc. and Sangamo Therapeutics, Inc. announced that they have executed a global licensing collaboration agreement to develop and commercialize ST-501 for tauopathies including…
Read More...